When compared with atorvastatin users, those taking rosuvastatin had an 8% higher chance of getting blood in their urine, a 17% higher risk of having protein in their urine, and a 15% higher chance of ...
Washington, DC - A letter in the correspondence section of the June 24, 2004 issue of the Lancet has called for the removal of rosuvastatin (Crestor ®, AstraZeneca) from the market. "The renal ...
The FDA is notifying health care professionals that drug interactions between atorvastatin (Lipitor), rosuvastatin (Crestor), and simvastatin (Zocor) and certain protease inhibitors for HIV or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback